Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, February 24, 2020
Abond CRO announced the hiring of Charley Bratton as Senior Vice President Corporate Marketing and Sales.
read more
Abpro announced the formation of a strategic partnership to advance two bispecific antibodies in key Asian markets including Greater China, Japan, and South Korea.
read more
Tuesday, January 06, 2026
Analytical Biological Services, a provider of biospecimen sourcing, cell culture services, and biorepository solutions for the global pharmaceutical and biotechnology industry, has acquired Cureline, a provider of specimen procurement and histology ...
read more
Wednesday, January 09, 2019
AbSci will apply its breakthrough E.coli manufacturing platform, SoluPro, and its novel optimization assay system, to two of Sanofi's biotherapeutic molecules.
read more
Wednesday, April 20, 2022
Absci Corporation announced the opening of the Absci AI Research Lab in Manhattan’s Plaza District.
read more
Tuesday, February 28, 2023
Absci Corporation, a generative AI drug creation company, announced its expansion into the European pharmaceutical market with the opening of its Innovation Center, located in Zug, Switzerland.
read more
Wednesday, October 05, 2022
Absolute Biotech has launched as a unified company joining together leading antibody-centric brands from around the world.
read more
Monday, November 13, 2017
Absorption Systems announces the acquisition of TGA Sciences, a contract R&D laboratory located in Medford, MA, just outside the pharma/biotech hub of Cambridge.
read more
Wednesday, September 25, 2013
Recipharm Stockholm is pleased to announce that the company was informed on September 20, 2013 by the R&D-based pharmaceutical company, Kyowa Hakko Kirin Co. Ltd. (Tokyo, Japan, President and CEO: Nobuo Hanai, “Kyowa Hakko Kirin”) that Abstral® ...
read more
Abveris announced the release of antibody sequences specific to the SARS-CoV-2 spike (S) protein into the public domain for unrestricted use.
read more
Abveris and Harbour Antibodies H2L2 BV announced a partnership to offer fully-human antibody discovery service that combines Abveris’ antibody discovery services with the Harbour H2L2 human transgenic mouse platform.
read more
Abzena and Argonaut Manufacturing Services, Inc. announced a strategic partnership to provide a fully integrated drug substance and drug product manufacturing solution for biopharmaceutical organizations.
read more
Thursday, November 06, 2025
Abzena and Mabqi announced the formation of a strategic partnership that will integrate Mabqi's antibody discovery capabilities with Abzena's development and manufacturing services, offering biopharma customers a more streamlined, end-to-end drug ...
read more
Abzena announced an accelerated program to IND.
read more
Abzena has invested $60m into a new facility for late phase and commercial cGMP manufacturing.
read more